Authors: BECK JF BUCHHOLZ F ULRICH WR BOER R SANDERS KH NIETHAMMER D GEKELER V

Citation: Jf. Beck et al., RHODAMINE-123 EFFLUX MODULATION IN THE PRESENCE OF LOW OR HIGH SERUM FROM CD56(-CELLS OR CD34(+) LEUKEMIC BLASTS BY B9309-068, A NEWLY DESIGNED PYRIDINE DERIVATIVE() HEMATOPOIETIC), Cancer letters, 129(2), 1998, pp. 157-163

Authors: ISE W HEUSER M SANDERS KH BECK J GEKELER V

Citation: W. Ise et al., P-GLYCOPROTEIN-ASSOCIATED RESISTANCE TO TAXOL AND TAXOTERE AND ITS REVERSAL BY DEXNIGULDIPINE-HCL, DEXVERAPAMIL-HCL, OR CYCLOSPORINE-A, International journal of oncology, 8(5), 1996, pp. 951-956

Authors: ELTZE M BOER R SANDERS KH PRUSSE W ULRICH WR

Citation: M. Eltze et al., B8805-033 - AN EXTREMELY ALPHA(1A)-ADRENOCEPTOR-SELECTIVE ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 35-35

Authors: GEKELER V BOER R UBERALL F ISE W SCHUBERT C UTZ I HOFMANN J SANDERS KH SCHACHTELE C KLEMM K GRUNICKE H

Citation: V. Gekeler et al., EFFECTS OF THE SELECTIVE BISINDOLYLMALEIMIDE PROTEIN-KINASE-C INHIBITOR GF 109203X ON P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE, British Journal of Cancer, 74(6), 1996, pp. 897-905

Authors: GEKELER V ISE W SANDERS KH ULRICH WR BECK J

Citation: V. Gekeler et al., THE LEUKOTRIENE LTD(4) RECEPTOR ANTAGONIST MK571 SPECIFICALLY MODULATES MRP ASSOCIATED MULTIDRUG-RESISTANCE, Biochemical and biophysical research communications, 208(1), 1995, pp. 345-352

Authors: GEKELER V BOER R ISE W SANDERS KH SCHACHTELE C BECK J

Citation: V. Gekeler et al., THE SPECIFIC BISINDOLYLMALEIMIDE PKC-INHIBITOR GF 109203X EFFICIENTLYMODULATES MRP-ASSOCIATED MULTIPLE-DRUG RESISTANCE, Biochemical and biophysical research communications, 206(1), 1995, pp. 119-126